Pharminox appoints Iain Ross as Chairman
Pharminox Limited announced that it has appointed Iain Ross as Non-executive Chairman. Mr Ross takes over from Dr Mario Polywka, who is stepping down as Chairman due to other commitments, but will remain on the Board in a non-executive capacity.
Mr Ross is currently Non-executive Chairman of Silence Therapeutics plc, the biotechnology company which recently merged with the US company Intradigm Corporation. He also holds non-executive directorships with a number of other companies in the sector.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Fatal overproduction of antibodies - Mutations in plasma cells play a key role in light chain amyloidosis

Click... Resistant bacteria caught in the act! - Scientists have succeeded in capturing unique images of protein soldiers that help bacteria resist drugs
Hesperion announces the opening of its Russian Moscow Office

Takara Bio and Eppendorf cooperate - Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency
New genetic links to MS also play roles in other autoimmune diseases

Dust mite allergens trigger inflammatory responses - Dust mite allergens activate the pulmonary immune system, thereby triggering allergies
